Jaroslav Jelinek
Has grant
Chief Scientific Officer
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Jaroslav Jelinek is the Chief Scientific Officer at the Coriell Institute for Medical Research in the United States. His research primarily focuses on the relationship between gut microbiota and epigenetic changes in colorectal cancer, as well as the effects of folic acid on DNA methylation and colitis-associated dysplasia. He has also investigated the impact of environmental factors on DNA methylation in different contexts, including lead exposure in canine populations.
Recent Grants
Grant: Close
Epigenetic Therapies - New Approaches
Open Date: 2021-08-16
Close Date: 2026-06-30
Grant: Close
Drug resistance gene transfer into hematopoietic cells for protection against toxic and mutagenic effects of chemoterapy.
Open Date: 1999-01-01
Close Date: 2001-12-31
Grant: Close
DNA-repair genes transfer to hematopoietic cells for protection against toxic and mutagenic effects of alkylating antitumor agents.
Open Date: 1996-01-01
Close Date: 1998-12-31
Grant: Close
Gene transfer into haemopoietic cells.
Open Date: 1993-01-01
Close Date: 1995-12-31
Grant: Close
Overcoming Urothelial Cancer Atezolizumab Resistance by Epigenetic Therapy
Open Date:
Close Date:
Articles (6)
Year:
2024
Year:
2023
Year:
2023
Year:
2022
Year:
2021
Year:
2021
Collaborators (5)
Daniel Leclerc
Research Institute of the McGill University Health Centre
Kumaraswamy naidu Chitrala
Assistant Professor
University of Houston
Himani Vaidya
Coriell Institute For Medical Research
Jozef Madzo
Assistant Professor
Coriell Institute For Medical Research
Jean-Pierre J Issa
Lewis Katz School of Medicine at Temple University
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.